Pinealon 20mg
Pinealon (EDR) is a synthetic tripeptide developed through Russian peptide bioregulator research, composed of the amino acid sequence Glutamic acid-Aspartic acid-Arginine (Glu-Asp-Arg). It is commonly utilized in laboratory and research settings to explore peptide signaling mechanisms, gene expression regulation, and cellular protection pathways within complex biological systems. Researchers have investigated Pinealon in a variety of preclinical and analytical models to better understand peptide-mediated neuroprotection, oxidative stress modulation, and cellular aging processes.
Pinealon is a small synthetic tripeptide studied for its proposed geroprotective and neuroprotective properties in experimental models, originally developed as part of a class of short peptide bioregulators.
Pinealon (EDR) is a synthetic tripeptide developed through Russian peptide bioregulator research, composed of the amino acid sequence Glutamic acid-Aspartic acid-Arginine (Glu-Asp-Arg). It is commonly utilized in laboratory and research settings to explore peptide signaling mechanisms, gene expression regulation, and cellular protection pathways within complex biological systems. Researchers have investigated Pinealon in a variety of preclinical and analytical models to better understand peptide-mediated neuroprotection, oxidative stress modulation, and cellular aging processes.
Pinealon is a small synthetic tripeptide studied for its proposed geroprotective and neuroprotective properties in experimental models, originally developed as part of a class of short peptide bioregulators.
For research use only. Not for human consumption.
Crown Peptides supplies research compounds for laboratory and analytical use. Proper handling, storage, and reconstitution are the responsibility of the qualified researcher. Shipping timelines are managed by the carrier and cannot be guaranteed by Crown Peptides.
Related products
